Nikolay Savchuk on LinkedIn
Nikolay Savchuk - San Diego, California, United States - LinkedIn
Location: San Diego · 500+ connections on LinkedIn. View Nikolay Savchuk's profile on LinkedIn, a professional community of 1 billion members.
Check out professional insights posted by Nikolay Savchuk,
9 "Nikolay Savchuk" profiles - LinkedIn
View the profiles of professionals named "Nikolay Savchuk" on LinkedIn. There are 9 professionals named "Nikolay Savchuk", who use LinkedIn to exchange ...
Nikolay Savchuk on LinkedIn: #traw
Congratulations to Traws Pharma (#TRAW) team with advancing their clinical studies for the best in class COVID19 antiviral therapy!
Nikolay Savchuk on LinkedIn: #drugdiscovery2024
Our ChemDiv team, Michael Nyman, Roman Timakhov, and Aleksandra Khotimchenko, had the incredible opportunity to attend the Drug Discovery Chemistry conference.
Nikolay Savchuk on LinkedIn: #ptpn2
Eilean Therapeutics a precision oncology company continues to expand its development portfolio of first and best in class by adding Ness ...
Nikolay Savchuk on LinkedIn: Congratulations to Lomond ...
Congratulations to Lomond Therapeutics a development stage precision hem-onc company with closing their APO financing of $44 million lead by ...
Nikolay Savchuk on LinkedIn: Eilean Therapeutics a biopharma ...
Eilean Therapeutics a biopharma targeting hematological malignancies and solid cancers resistant to treatment will present summary of its ...
Nikolay Savchuk on LinkedIn: Congratulations to Trawsfynydd ...
Congratulations to Trawsfynydd Therapeutics and Onconova Therapeutics (ONTX). They merged best in class development stage CDK4/6 , influenza ...
Nikolay Savchuk on LinkedIn: Brenig Therapeutics Unveils Superior ...
Congratulations to the Brenig Therapeutics' team for solving for safety and tolerability of a disease modifying PD therapy with highly BBB ...
Nikolay Savchuk on LinkedIn: Congratulations to Eilean ...
Congratulations to Eilean Therapeutics team with another development milestones for their best in class balamenib MEN1/MLL inhibitor!
Nikolay Savchuk on LinkedIn: ChemDiv Establishes a Cutting-edge ...
We appreciate diligent work of our partners ChemDiv, Inc.San Diego based drug discovery and drug development solutions provider.
Nikolay Savchuk on LinkedIn: We welcome Luba Greenwood as a ...
We welcome Luba Greenwood as a newly appointed independent director of Traws Pharma developing best in class novel antiviral, immunology and ...
Nikolay Savchuk on LinkedIn: This seminar might share some latest ...
This seminar might share some latest insights for new targets in oncology for industry and academic cancer researchers.
Nikolay Savchuk on LinkedIn: #io
We enjoy a strong support and care from ChemDiv to over 30 companies in our investment portfolio. We welcome ChemDiv growth and further ...
Nikolay Savchuk on LinkedIn: #viriom #chromis #chemrar #avifavir ...
Viriom's partner #Chromis (a #ChemRar Group company) announced that #Avifavir, the first direct oral antiviral treatment of #COVID19 was registered in…
Nikolay Savchuk - LinkedIn, Twitter - Clay.earth
Nikolay Savchuk is a prominent figure in the investment and startup ecosystem, currently serving as a Partner at i2020 Accelerator. He is based...
Nikolay Savchuk on LinkedIn: 'A silver lining'
Our portfolio company Vaxxas micro-array patches offer multiple advantages not only to vaccine but to high potency/low volume long acting ...
Nikolay Savchuk on LinkedIn: Trawsfynydd Therapeutics Inc a ...
Trawsfynydd Therapeutics Inc a member of Expert Systems global discovery and development accelerator launched first in human studies of its ...
Nikolay Savchuk on LinkedIn: Great presentation at AACR: hunting ...
Great presentation at AACR: hunting for novel cancer targets from Tudor and ExpertSystems.inc accelerator.